"Galantamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.
| Descriptor ID |
D005702
|
| MeSH Number(s) |
D03.132.052.500 D03.633.100.079.525
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Galantamine".
Below are MeSH descriptors whose meaning is more specific than "Galantamine".
This graph shows the total number of publications written about "Galantamine" by people in this website by year, and whether "Galantamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Galantamine" by people in Profiles.
-
Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018 07 10; 281:139-177.
-
Schultz BR, Takeshita J, Goebert D, Takeshita S, Lu BY, Guilloux A, Higa J. Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders. Psychogeriatrics. 2017 Nov; 17(6):423-429.